Broad secures US discovery win in CRISPR EPO dispute

22-06-2018

Broad secures US discovery win in CRISPR EPO dispute

Pablo_K / iStockphoto.com

The US Court of Appeals for the First Circuit has confirmed that a request to obtain discovery for use in a foreign proceeding, in this case at the European Patent Office (EPO), will be denied unless the relevance of that discovery can be shown.


Intellia, The Broad Institute, CRISPR, gene editing, genomics, gene sequencing, European Patent Office, US Court of Appeals for the First Circuit

LSIPR